Table 1.

Demographics for controls (C: 1 – 11) and patients (P: 12 – 30).

Subject	Status	Agea/Gender	Disease durationa	Psychotropic Medication
1	C	45/M	-	-
2	C	31/M	-	-
3	C	29/F	-	-
4	C	36/M	-	-
5	C	43/M	-	-
6	C	24/F	-	-
7	C	55/F	-	-
8	C	26/F	-	-
9	C	29/F	-	-
10	C	22/M	-	-
11	C	31/F	-	-
12	P	41/M	22	Fluphenazine
13	P	44/F	27	Quetiapine
14	P	43/M	18	Haloperidol, quetiapine
15	P	52/M	32	Citalopram
16	P	51/F	15	Gabapentin, lithium, ziprasidone
17	P	23/M	3	Risperidone
18	P	47/M	31	Fluoxetine, risperidone, valproic acid, trazodone
19	P	44/M	26	Clozapine, valproic acid
20	P	26/M	8	Ziprasidone
21	P	29/F	8	Buproprion, aripiprazole, fluphenazine
22	P	42/F	23	Ziprasidone, buproprion, eszopiclone
23	P	22/M	4	Clozapine
24	P	48/M	23	Quetiapine
25	P	34/M	5	Risperidone
26	P	30/F	10	Risperidone
27	P	49/F	31	Aripiprazole
28	P	51/F	35	NA
29	P	43/F	20	Aripiprazole, escitalopram, fluphenazine
30	P	52/M	30	Aripiprazole, valproic acid, hydroxyzine, paroxetine, trazodone

^aYears, “-“=not applicable.